Sharekhan

Global Health Ltd

Fri 22/05/2026,15:56:25 | NSE : MEDANTA

₹ 1238.10-2.10 (-0.17%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1240.20

Previous Close

₹ 1240.20

Volume

75889

Mkt Cap ( Rs. Cr)

₹33286.55

High

₹ 1250.00

Low

₹ 1231.30

52 Week High

₹ 1456.50

52 Week Low

₹ 956.00

Book Value Per Share

₹ 141.44

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Global Health Ltd

Your Vote -

Buy

38.10%

Hold

52.38%

Sell

9.52%

38.10%

42 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1238.10

501

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

501

Option Chain

Analyzes market sentiment, predicts Global Health Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Global Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    23 May 2026, 3:53PM Intimation under Regulation 30 of Listing regulations regarding Allotment of Shares.
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 May 2026, 6:06PM Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2026, 6:01PM Global Health Limited has informed the Exchange about Schedule of Analyst meet.
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 May 2026, 5:59PM Intimation under SEBI Listing Regulations regarding schedule of Analyst Meet.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    20 May 2026, 10:14AM Global Health Limited has informed the Exchange about Announcement under Regulation 30 of Listing regulations for Earning Call Transcript.
  • Global Health - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    20 May 2026, 10:10AM Announcement under Regulation 30 of Listing Regulations 2015 for Earning Conference call Transcript.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    15 May 2026, 4:12PM Global Health Limited has informed the Exchange about Link of Recording
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    15 May 2026, 4:09PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Audio Recording.
  • Global Health - Copy of Newspaper Publication

    15 May 2026, 11:47AM Global Health Limited has informed the Exchange about Copy of Newspaper Publication
  • Global Health - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 May 2026, 6:49PM Investor Presentation for the fourth quarter and year ended March 31, 2026 results of the Company.
  • Global Health - Investor Presentation

    14 May 2026, 6:48PM Global Health Limited has informed the Exchange about Investor Presentation
  • Global Health - Press Release

    14 May 2026, 6:43PM Global Health Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "" press release for the fourth quarter and year
  • Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    14 May 2026, 6:43PM Press Release for the fourth Quarter and year ended March 31, 2026 results.
  • Global Health - Resignation of Director/KMP/SMP

    14 May 2026, 5:05PM Global Health Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Global Health - Outcome of Board Meeting

    14 May 2026, 4:57PM Global Health Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Global Health - Dividend

    14 May 2026, 4:57PM Global Health Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2026, recommended Final Dividend of Rs. 0.50 pe
  • Global Health - Change in Management

    14 May 2026, 4:57PM Global Health Limited has informed the Exchange about change in Management
  • Global Health - Announcement under Regulation 30 (LODR)-Change in Management

    14 May 2026, 5:03PM Annoucement Regarding the Change in Management
  • Global Health - Announcement under Regulation 30 (LODR)-Dividend Updates

    14 May 2026, 4:58PM Intimation of Outcome of Board Meeting for Recommending Final Dividend.
  • Global Health Q4 net profit up 32.89% at Rs 124.13 cr

    14 May 2026, 4:50PM The company reported standalone net profit of Rs 124.13 crore for the quarter ended March 31, 2026 as compared to Rs 93.41 crore in the same period la
  • Global Health - Board Meeting Outcome For Intimation Of Audited Financial Results.

    14 May 2026, 4:49PM Board Meeting Outcome for Intimation of Audited Financial Results under Regulation 33 of Listing Regulations.
  • Global Health - Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulation

    14 May 2026, 4:39PM Outcome for Board Meeting held today for approving Audited Financials and Recommending Final Dividend.
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 May 2026, 6:24PM Intimation for Earning Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    11 May 2026, 6:18PM Global Health Limited has informed the Exchange about Schedule of meet.
  • Global Health - ESOP/ESOS/ESPS

    11 May 2026, 11:42AM Global Health Limited has informed the Exchange regarding Grant of 10000 Options.
  • Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates

    11 May 2026, 11:46AM It is informed that Nomination & Remuneration Committee in its Meeting held today i.e. May 11, 2026 has made a grant of 10,000 Options under GHL LTIP
  • Global Health - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Financi

    6 May 2026, 3:42PM Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and ap
  • Global Health - Press Release

    27 Apr 2026, 3:10PM Global Health Limited has informed the Exchange regarding a press release dated April 27, 2026, titled Medanta Expands Indore Presence with Takeover
  • Global Health - Capacity addition

    27 Apr 2026, 2:45PM Global Health Limited has informed the Exchange about Capacity addition
  • Global Health - Outcome of Board Meeting

    27 Apr 2026, 2:42PM Global Health Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2026.
  • Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    27 Apr 2026, 3:36PM Intimation of Press Release (Earlier press release dated April 27, 2026 was inadvertently filed under the revised tab).
  • Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

    27 Apr 2026, 3:07PM Intimation of Press Release titled as \Medanta Expands Indore Presence with Takeover of 80 Bed Cancer Hospital\ dated April 27, 2026.
  • Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates

    27 Apr 2026, 2:43PM Board Meeting intimation under Regulation 30 of SEBI Listing Regulations held today, April 27, 2026.
  • Global Health - Announcement under Regulation 30 (LODR)-Acquisition

    27 Apr 2026, 2:41PM Intimation under Regulation 30 of SEBI Listing Regulations.
  • Global Health - ESOP/ESOS/ESPS

    22 Apr 2026, 5:00PM Global Health Limited has informed the Exchange regarding Allotment of 61500 Shares.
  • Global Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    22 Apr 2026, 4:57PM Intimation under Regulation 30 of Listing Regulations regarding Allotment of Shares.
  • Global Health has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    13 Apr 2026, 6:30PM As of March 2026, 33.01% is owned by Indian Promoters, 66.92% by Public and 0.08% by Non Promoters-Non Public. <p align=justify> Institutional holds 2
  • Global Health - Disclosure under SEBI Takeover Regulations

    8 Apr 2026, 7:25PM Dr. Naresh Trehan has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Global Health - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    2 Apr 2026, 5:59PM Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Global Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    2 Apr 2026, 5:57PM Please find attached herewith the Certificates issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 by RTA for
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Mar 2026, 4:28PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 Mar 2026, 4:26PM Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
  • Global Health - Press Release

    25 Mar 2026, 3:57PM Global Health Limited has informed the Exchange regarding a press release dated March 25, 2026, titled ""Medanta to set up a 400-bed hospital in the c
  • Global Health - Capacity addition

    25 Mar 2026, 3:51PM Global Health Limited has informed the Exchange about Capacity addition
  • Global Health - Adoption of new line(s) of business

    25 Mar 2026, 3:49PM Global Health Limited has informed the Exchange about Adoption of new line(s) of business
  • Global Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 Mar 2026, 3:55PM Press release dated March 25, 2026 titled \ Medanta to set up a 400 bed hospital in the centre of Varanasi, further strengthening its Uttar Pradesh fo
  • Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates

    25 Mar 2026, 3:50PM Board Meeting Intimation under Regulation 30 of SEBI Listing Regulations held today i.e. March 25, 2026.
  • Global Health - ESOP/ESOS/ESPS

    24 Mar 2026, 2:19PM Global Health Limited has informed the Exchange regarding Grant of 10000 Options.
  • Global Health - Announcement under Regulation 30 (LODR)-Meeting Updates

    24 Mar 2026, 2:18PM It is informed that Nomination and Remuneration Committee in its meeting held today i.e. March 24, 2026 has made a grant of 10,000 options under GHL L
  • Global Health - Trading Window

    24 Mar 2026, 1:25PM Global Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Mar 2026, 5:51PM Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Mar 2026, 5:51PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Mar 2026, 5:53PM Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
  • Global Health - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    14 Mar 2026, 5:38PM Intimation of Scrutinizer Report dated March 14, 2026 of Postal Ballot
  • Global Health - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    14 Mar 2026, 5:34PM Intimation of Voting Results as per Regulation 44 and 30 of SEBI Listing Regulations 2015.
  • Global Health - Shareholders meeting

    14 Mar 2026, 5:29PM Global Health Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Mar 2026, 6:13PM Intimation under SEBI Listing Regulations regarding Schedule of Analyst Meet.
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Mar 2026, 6:13PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Mar 2026, 7:11PM Global Health Limited has informed the Exchange about Schedule of meet
  • Global Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Mar 2026, 7:08PM Intimation under SEBI Listing Regulations regarding schedule of Analyst Meet.
  • Global Health

    26 Jun 2023 , 12:08PM Global Health or Medanta’s credit rating has been revised to CRISIL AA-/Stable from CRISIL A+/Positive by CRISIL. Positive for the stock.

Key fundamentals

Evaluate the intrinsic value of Global Health Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 4695.226 3638.05 2907.979 2590.4047 1861.8816
Liabilities 4695.226 3638.05 2907.979 2590.4047 1861.8816
Equity 53.738 53.717 53.701 53.639 50.6448
Gross Profit 754.861 765.016 497.35 402.2721 374.836
Net Profit 496.201 461.528 360.891 263.2452 218.784
Cash From Operating Activities 573.317 527.666 340.64 430.5298 235.4034
NPM(%) 13.37 14.4 15.82 13.43 12.4
Revenue 3709.378 3204.146 2280.008 1959.4462 1764.2492
Expenses 2954.517 2439.13 1782.658 1557.1741 1389.4132
ROE(%) 13.04 12.13 9.49 6.92 5.75

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.5 25 0 1211.9
22 Aug 2025 0.5 25 0 1243.3

Peers

Other companies within the same industry or sector that are comparable to Global Health Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
No Records Found

Company Info

Our Company was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by our Shareholders in the EGM held on July 31, 2021 and consequently, the name of our Company was changed to `Global Health Limited' and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e., Investor Selling Shareholder) invested in our Company-1st Joint Commission International ("JCI") accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary, GHPPL, entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital's outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital's inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy 2020 -Global Health listed as a best performing ASX small cap. -Global Health's Lifecard featured in series of Product Snapshots in the Australian healthtech sector. -Global Health joins BP's approved integrator network, goes live with SafeScript 2022 -Global Health is announce that it has secured two significant contracts for Homeless Healthcare (WA) and Peninsula Health (VIC). -Global Health Secures Three Key Contracts with Private Hospitals in NSW and WA. -Global Health brings health management online with new software solutions 2024 -The Company Approved the acquisition of land in Mumbai'by MHADA. -The Ho'nble National Company Law Tribunal, New Delhi Branch, Approved of Merger between MHPL and GHL. 2024-The Company has approved the scheme of Amalgamation between the Company and Medanta Holdings Private Limited, wholly-owned subsidiary of the Company.-The Company have approved the acquisition of land parcel measuring 8859.24 sq. meters, on lease basis, offered by Mumbai Housing and Area Development Authority (MHADA) under online e-tenders, at a bid amount  of Rs 125.11 crores (approx.), situated at Mauje-Oshiwara, Jogeshwari, CTS No. 31, 32 (part), 33 (part), 37 (part), Mumbai, Maharashtra.-Global Health Limited has been granted of 17,50,000 Equity Shares for Primary Allotment and 53,70,147 Equity Shares (i.e. 2% of the paid-up capital of the Company as on March 31, 2024 for Secondary Acquisition under GHL LTIP 2024 Schemes)2025-Company has purchased land from Assam Electricity Grid Corporation limited to establish super specialty hospital at Guwahati at a consideration of Rs. 30 Crores.-Global Health Limited (Medanta) has commenced construction for its upcoming 400 bed super-specialty hospital in Guwahati.

Our Company was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the RoC. Our Company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by our Shareholders in the EGM held on July 31, 2021 and consequently, the name of our Company was changed to `Global Health Limited' and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.Milestones:2009Gurugram hospital was established2011-Received the NABH accreditation for Gurugram hospital-Received the NABL accreditation for Gurugram hospital2013-Carlyle (i.e., Investor Selling Shareholder) invested in our Company-1st Joint Commission International ("JCI") accreditation for the hospital at Gurugram2014-Received the NABH (blood bank) accreditation for Gurugram hospital-Entered into a 27-year lease for hospital at Indore2015-Temasek invested in our Company-Entered into a 15-year lease for hospital at Ranchi-Our subsidiary, GHPPL, entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna2016-Received the NABH accreditation for Indore hospital-Entered into a 90-year lease for our hospital at Noida (which is under construction)2018Received the NABH accreditation for Ranchi hospital2019Commencement of operations of new hospital at Lucknow2020-Patna hospital's outpatient department facility launched-Gurugram hospital outpatient department pharmacy taken in-house-Received the Research Ethics NABH accreditation2021-Lucknow hospital outpatient department pharmacy taken in-house-Indore hospital outpatient department pharmacy taken in-house-Ranchi hospital outpatient department pharmacy taken in-house-Launch of outpatient department pharmacy at south Delhi clinic2022-Patna hospital's inpatient department facility commenced operations-Received the NABH accreditation for Lucknow hospital-Launch of Patna hospital outpatient department pharmacy 2020 -Global Health listed as a best performing ASX small cap. -Global Health's Lifecard featured in series of Product Snapshots in the Australian healthtech sector. -Global Health joins BP's approved integrator network, goes live with SafeScript 2022 -Global Health is announce that it has secured two significant contracts for Homeless Healthcare (WA) and Peninsula Health (VIC). -Global Health Secures Three Key Contracts with Private Hospitals in NSW and WA. -Global Health brings health management online with new software solutions 2024 -The Company Approved the acquisition of land in Mumbai'by MHADA. -The Ho'nble National Company Law Tribunal, New Delhi Branch, Approved of Merger between MHPL and GHL. 2024-The Company has approved the scheme of Amalgamation between the Company and Medanta Holdings Private Limited, wholly-owned subsidiary of the Company.-The Company have approved the acquisition of land parcel measuring 8859.24 sq. meters, on lease basis, offered by Mumbai Housing and Area Development Authority (MHADA) under online e-tenders, at a bid amount  of Rs 125.11 crores (approx.), situated at Mauje-Oshiwara, Jogeshwari, CTS No. 31, 32 (part), 33 (part), 37 (part), Mumbai, Maharashtra.-Global Health Limited has been granted of 17,50,000 Equity Shares for Primary Allotment and 53,70,147 Equity Shares (i.e. 2% of the paid-up capital of the Company as on March 31, 2024 for Secondary Acquisition under GHL LTIP 2024 Schemes)2025-Company has purchased land from Assam Electricity Grid Corporation limited to establish super specialty hospital at Guwahati at a consideration of Rs. 30 Crores.-Global Health Limited (Medanta) has commenced construction for its upcoming 400 bed super-specialty hospital in Guwahati.

Parent Organisation

Global Health Ltd.

Founded

13/08/2004

Managing Director

Dr.Naresh Trehan

NSE Symbol

MEDANTAEQ

FAQ

OPEN FREE* DEMAT ACCOUNT